Publication | Closed Access

Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia

Hematological MalignancyChronic Myelomonocytic LeukemiaAutoimmune DiseaseMalignant Blood DisorderImmunologyHematologyAutoimmunityPharmacotherapyImmunotherapyMedicineInflammatory DisordersMyelodysplastic SyndromesMyeloid Neoplasia